Manufacturers Report on Patient Benefits of Oral RI Drugs

January 24, 2012
The Japan Radioisotope Association (JRIA) on January 21 held a lecture meeting on oral radioisotope (RI) drugs in Tokyo, where manufacturers reported on the current situation of the drugs. FUJIFILM RI Pharma reported that the use of the malignant lymphoma...read more